Seres Therapeutics (MCRB)

Seres Therapeutics specialises in treatments for microbiome complaints and disorders. The firm recently announced positive Phase-3 trials for its drug to treat C.difficile infections. Nestle are a big shareholder which I personally find pretty interesting… Cough AIMT Cough

Thanks! :smile: